|
(V366) |
Growth Differentiation Factor 15 is a novel biomarker for prediction of heart failure events in chronic kidney disease |
| |
|
K. Rogacev, K. Duffin, A. Zawada, D. Laska, S. Seiler-Mußler, M. Breyer, D. Fliser, J. Voelker, H. Thiele, G. Heine (Lübeck, Bad Homburg v.d. Höhe, Indianapolis, Homburg; Indianapolis, US) |
|
|
Diskussion |
|
(V367) |
Galectin-3 is related to atherosclerotic burden in patterns of heart failure – Data from the population-based Gutenberg Health Study |
| |
|
T. Eichkorn, J. Prochaska, C. Jünger, A. Schulz, A. Leuschner, E. Pefani, N. Arnold, S. Göbel, S.-O. Tröbs, S. Schwuchow, K. Lackner, T. Münzel, P. S. Wild (Mainz) |
|
|
Diskussion |
|
(V368) |
Blood based MicroRNA profiling in patients with cardiac amyloidosis |
| |
|
A. A. Derda, A. Pfanne, P. J. Kennel, C. Schulze, T. Thum (Hannover, Jena; New York, US) |
|
|
Diskussion |
|
(V369) |
Complex changes in plasma sphingolipids are associated with heart failure |
| |
|
A. Polzin, P. Keul, L. K. Dannenberg, A. Mohring, M. Gräler, T. Zeus, M. Kelm, B. Levkau (Düsseldorf, Essen, Jena) |
|
|
Diskussion |
|
(V370) |
Prognostic significance of multiple cardiac biomarkers in diagnostically naïve patients with suspected heart failure – comparison with a clinical base model |
| |
|
S. Demirbas, C. Morbach, D. Oder, V. Holzendorf, C. Prettin, J. Vollert, S. Störk, G. Ertl, C. E. Angermann (Würzburg, Leipzig, Hennigsdorf) |
|
|
Diskussion |
|
(V371) |
Characterization of Myocardial and Serum Levels of Phosphodiesterase 9A in Patients with Heart Failure – Relation to Left Atrial Size and Right Ventricular Function |
| |
|
C. Besler, K.-P. Rommel, A. Burkert, M. von Röder, S. Blazek, K. Fengler, A. Linke, G. C. Schuler, V. Adams, P. Lurz (Leipzig) |
|
|
Diskussion |